December 9, 2023

Rising Incidence of Chronic Ailments and COVID-19 Severity Drive Growth in the C-Reactive Protein Testing Market

The global C-Reactive Protein (CRP) testing market is experiencing remarkable growth, driven by the escalating incidence of chronic diseases, including cancer, cardiovascular disorders, inflammatory bowel diseases, and arthritis. Early identification and diagnosis of these conditions play a crucial role in improving patient outcomes and increasing the likelihood of successful treatment. As a result, the adoption of CRP tests continues to rise, bolstering the growth of the CRP testing market.

COVID-19 Severity Assessment: A Catalyst for Growth

The COVID-19 pandemic has had a profound impact on the CRP testing market since 2020. Researchers from Mohammed VI University of Health Sciences and the National Center for Biotechnology Information explored the application of CRP as an early indicator for diagnosing COVID-19 infection and assessing its severity. According to the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), CRP has shown promise as a potential marker for evaluating the prognosis and therapeutic monitoring of SARS-CoV-2 infection.

CRP testing has become an essential tool in the assessment and follow-up of COVID-19 infections, and companies like Aidian and Abbott have introduced products to support the diagnosis of COVID-19 infection. Aidian’s QuickRead Go CRP tests and Abbott’s Affinion 2 Analyzer CRP test provide quick and accurate results, aiding in the management of COVID-19 patients. This increased demand for CRP testing in the clinical research related to COVID-19 infection severity is expected to drive the growth of the CRP testing market.

CRP Testing in Cardiovascular Diseases: A Growing Application

The application of CRP testing in the diagnosis of cardiovascular disorders is gaining momentum worldwide. The prevalence of cardiovascular diseases has led to the need for effective and rapid diagnostic methods. CRP can serve as an indicator for detecting cardiovascular disorders by identifying atherosclerosis, which involves the buildup of cholesterol inside blood vessel walls, leading to inflammation. Patients with cardiovascular disorders typically exhibit elevated levels of CRP. Moreover, high-sensitivity CRP levels rise with various risk factors such as smoking, obesity, and aging. Individuals who are overweight or habitual smokers are more likely to have elevated CRP levels, indicating a potential risk of developing cardiovascular diseases. This increasing incidence of cardiovascular diseases is driving the demand for CRP testing in the identification of cardiovascular disorders.

See also  Gas Cleaning Technologies Market on Track to Reach US$40 Billion by 2030 with a 5.2% CAGR

North America Expected to Lead the Global CRP Testing Market

Developed economies in North America are poised for significant growth in the use of CRP testing. The region is characterized by the adoption of advanced healthcare technologies and a growing emphasis on clinical research. The rising prevalence of cancer in North America, particularly in the United States, is expected to drive the demand for CRP testing. Prostate cancer, in particular, is a leading cause of cancer-related deaths in the United States.

Additionally, the occurrence of coronary artery disease (CAD) is a major concern in the United States. The Center for Disease Control and Prevention (CDC) reports that approximately 18 million adults aged 20 and above are expected to develop CAD, with 2 in 10 deaths among adults aged 65 and above attributed to coronary heart disease. The region’s favorable government policies regarding healthcare reimbursements and infrastructure further support the adoption of CRP testing. Consequently, North America is poised to maintain its dominance in the CRP testing market in the years to come.

CRP Testing Market: Leading Players

Key players in the CRP testing market include Abbott Laboratories, Abaxis Inc., Beckman Coulter Inc., Laboratory Corporation of America Holdings, and F. Hoffman-La Roche AG.

Global Industry Analysis (2018 – 2021) – Growth Trends and Market Forecast (2022 – 2029):

Our Related Report:

Electric Bed Market

Vibrating Mesh Nebulizer Market


Fairfield Market Research 

London, UK

UK +44 (0)20 30025888    

USA (Toll-free) +1 (844) 3829746 



LinkedIn | Twitter

This press release first seen on Brilad